União Europeia - polonês - EMA (European Medicines Agency)

sun pharmaceutical industries (europe) b.v. - ertapenem sodu - infekcje bakteryjne - ertapenem - treatmentertapenem sun is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4. 4 i 5. 1):- intra-abdominal infections- community acquired pneumonia- acute gynaecological infections- diabetic foot infections of the skin and soft tissue (see section 4. 4)preventionertapenem sun is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4. należy uwzględnić oficjalne zalecenia dotyczące właściwego stosowania antybiotyków agentów.

União Europeia - polonês - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - teryparatyd - osteoporosis; osteoporosis, postmenopausal - wapń homeostaza - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

União Europeia - polonês - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, type 2 - leki stosowane w cukrzycy - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. potrójnej terapii skojarzonej), jako uzupełnienie diety i ćwiczeń fizycznych u pacjentów niedostatecznie kontrolowanych o ich maksymalnej tolerowanej dawki sulfonylomocznika z metforminą i. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

União Europeia - polonês - EMA (European Medicines Agency)

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - Środki przeciwnowotworowe - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Polônia - polonês - Ministerstwo Rolnictwa i Rozwoju Wsi

proagri sp. z o.o. ul. kolejowa, 56-420 bierutów - fenpropidyna - 750 g - fungicyd

Polônia - polonês - Ministerstwo Rolnictwa i Rozwoju Wsi

elvita sp. z o.o. ul. dworcowa, 87-400 golub-dobrzyń - fenpropidyna - 750 g - fungicyd

União Europeia - polonês - EMA (European Medicines Agency)

intervet international b.v. - antygen podjednostkowy orf2 typu 2 cirkowirusa świń - immunologicals for suidae, inactivated viral vaccines - wieprzowy - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by pcv2 infection.  to reduce loss of daily weight gain and mortality associated with pcv2 infection.

União Europeia - polonês - EMA (European Medicines Agency)

photonamic gmbh & co. kg - chlorowodorek kwasu 5-aminolewulinowego - glejak - Środki przeciwnowotworowe - gliolan jest wskazany u dorosłych pacjentów do wizualizacji tkanki złośliwej podczas operacji glejaka złośliwego (Światowa organizacja zdrowia stopień iii i iv).

União Europeia - polonês - EMA (European Medicines Agency)

advanz pharma limited - kwas obeticholic - marskość wątroby, żółć - terapia żółci i wątroby - ocaliva jest wskazany w leczeniu podstawowym dróg żółciowych zapalenie dróg żółciowych (znany również jako pierwotną marskość żółciową) w połączeniu z kwas ursodeoksycholowy (kwas ursodeoksycholowy) u dorosłych pacjentów z niewystarczającą odpowiedzią na kwas ursodeoksycholowy lub w monoterapii u dorosłych nie tolerują kwas ursodeoksycholowy.

Polônia - polonês - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

bluefish pharmaceuticals ab - mirtazapinum - tabletki ulegające rozpadowi w jamie ustnej - 15 mg